Advocacy intelligence hub — real-time data for patient organizations
Appalachian State University — NA
Hopital La Rabta — NA
Fred Hutchinson Cancer Center — PHASE2
University of Sao Paulo General Hospital — NA
Hydrocortisone: FDA approved
replacement therapy in pediatric patients 5 years of age and older with adrenocortical insufficiency
Qifu Li
Northwell Health — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Hydrocortisone
(HYDROCORTISONE)Orphan drugPreferred Pharmaceuticals Inc.
Corticosteroid [EPC]
Stefanie Hahner, MD
University of Wuerzburg
Gudmundur Johannsson, Professor
Vastra Gotaland Region, Sahlgrenska University Hospital
Simon H Pearce, MD
Newcastle University
Paal Methlie, MD
University of Bergen. Helse-Bergen HF
Valentina Morelli, PHD
Istituto Auxologico Italiano
R Ross
Neurocrine UK Limited